ID   HSC-40A
AC   CVCL_A386
SY   HSC40A
DR   CGH-DB; 107-1
DR   CGH-DB; 9002-4
DR   Cosmic; 876558
DR   Cosmic; 877038
DR   JCRB; JCRB1867
DR   Wikidata; Q54896392
RX   PubMed=1846312;
RX   PubMed=15723654;
CC   Population: Japanese.
CC   Doubling time: 28-30 hours (PubMed=1846312).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1867
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A385 ! HSC-39
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
RX   PubMed=1846312;
RA   Yanagihara K., Seyama T., Tsumuraya M., Kamada N., Yokoro K.;
RT   "Establishment and characterization of human signet ring cell gastric
RT   carcinoma cell lines with amplification of the c-myc oncogene.";
RL   Cancer Res. 51:381-386(1991).
//
RX   PubMed=15723654; DOI=10.1111/j.1349-7006.2005.00016.x;
RA   Takada H., Imoto I., Tsuda H., Sonoda I., Ichikura T., Mochizuki H.,
RA   Okanoue T., Inazawa J.;
RT   "Screening of DNA copy-number aberrations in gastric cancer cell lines
RT   by array-based comparative genomic hybridization.";
RL   Cancer Sci. 96:100-110(2005).
//